FDBusiness.com

Extended use of Glavonoid™

 Breaking News
  • The Zamora Company Moves into American Whiskey The Zamora Company, a Spanish fifth generation, family-owned global wine and spirits business headquartered in Madrid, has acquired an equity stake in Yellow Rose Distilling, a leading American whiskey distiller in Houston, Texas. The Zamora Company is best known for Licor 43, Spain’s leading liqueur brand, as well as Villa Massa Limoncello and a wide [...]...
  • Dunnes Reclaims Top Spot in Irish Grocery Market The latest grocery market share figures from Kantar Worldpanel in Ireland, for the 12 weeks ending 5 November 2017, reveal that Dunnes Stores has returned to the top spot for the first time in nine months, capturing a 22.4% share of the market. David Berry, director at Kantar Worldpanel, comments: “Dunnes Stores traditionally posts a strong performance towards [...]...
  • Cornish Kern From the UK Named World Champion Cheese 2017 Cornish Kern, an alpine-style cheese made by the UK’s Lynher Dairies Cheese Company, has been crowned World Champion Cheese at the 30th annual World Cheese Awards, after just a few years in development. This buttery medium-hard cheese, with a deep aroma and caramel notes, rose to the top among 3,000 entries. The 30th anniversary edition of the awards [...]...
  • GNT Group Supports Next Generation of Food Scientists The GNT Young Scientist Award 2017 goes to Caroline Buvé of Katholieke Universiteit Leuven, Belgium. At the 31st EFFoST International Conference, which was held in Sitges, Spain, from 13th to 16th November, she stood out with her research on quantifying colour changes of pasteurized strawberry juices during storage by integrating analytical and acceptability data. Second and third place went [...]...
  • How Conformity Can Deliver Tangible Business Benefits For Packaged Food Manufacturers Manufacturers and brand owners are under immense pressure to repeatedly produce conforming, high quality, safe and well-presented packaged food to meet industry requirements. Increasingly stringent legislation, innovations in packaged product design and evolving customer expectations mean the need for conformity has never been greater. Industry expert Mettler Toledo has published a free, comprehensive white paper ‘Ensuring Conformity [...]...

Extended use of Glavonoid™

Extended use of Glavonoid™
September 08
15:56 2015

Further approved fields of application enable new products to be launched

 Brussels (Belgium), September 2015Kaneka Pharma Europe, developer and patent holder of the liquorice root extract Glavonoid™, has successfully secured extended use approval for the novel food ingredient from the European Commission. Glavonoid™ offers unique support in reducing visceral fat. Besides being used in food supplements and beverages based on milk, yoghurt, fruit and vegetables, as accredited by its Novel Food status since 2011, Glavonoid can now also be applied in foods intended for medical purposes and energy-restricted diets for weight reduction.  

In DNA microarray analysis, Glavonoid™ has been shown to exhibit a two-way efficiency mechanism: On the one hand, it increases the body’s own fat burning ability by up-regulating genes involved in fatty acid oxidation, and on the other, it decreases fat development by down-regulating genes that are involved in fatty acid synthesis. Besides lowering body weight and BMI (body mass index), Glavonoid™ may also optimize cholesterol and blood glucose levels[1]. Derived from liquorice root (Glycyrrhiza glabra L.) via an advanced patented process, Glavonoid™ is 100 per cent free from glycyrrhizinic acid and contains 30 per cent liquorice glabra polyphenols. The allowed daily dose is 120 mg for adults.

Peter Lambrechts, Business Development Manager at Kaneka’s Quality of Life Division, who successfully guided the approval process, states: “With visceral fat being the main risk factor for the development of metabolic syndromes and other chronic diseases such as cardiovascular illnesses, we see extremely promising market potential here. The new regulatory status for Glavonoid™ paves the way for manufacturers to create new products targeting markets such as weight management and body shaping.

Glavonoid™ can be used in supplements as a single ingredient or as part of a multi-component system. It can also be included in products aimed at the sports and fitness market, as well as healthy ageing.

[1]Tominaga, Y. et al.: Obesity Research & Clinical Practice (2009) 3, 169-178

About Author

admin

admin

Related Articles



Food & Drink Business Conference & Exhibition 2016

Upcoming Events

  • November 28, 2017Fi Europe
  • December 4, 2017Plastics and Paper in Contact with Foodstuffs 2017
  • January 8, 2018RAI Exhibition
  • January 16, 2018Sival Plant Production Trade Show
AEC v1.0.4

find food jobs

The Magazine

F&D Business Preferred Suppliers

New Subscriber





Subscribe Here



Advertisements